DUBLIN--(BUSINESS WIRE)--The "Global Cardiac Rhythm Management Devices Market - Segmented by Product Type and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.
The global cardiac rhythm management devices market is expected to register a CAGR of 4.8% during the forecast period, 2018-2023.
The increasing instances of cardiovascular disorders is one of the foremost factors driving the cardiac rhythm management devices market. Globally, cardiovascular diseases account for more than 30% deaths, amounting to 17 million people. Also, nearly 33.5 million people, globally, are suffering from atrial fibrillation (AFib), which is the most common type of serious arrhythmia. With the rise in the aging population in America and Europe, a number of patients suffering heart rhythm disorders are likely to witness an increase, and this is a cause for concern.
The therapeutic radiation used in cancer treatment can influence the operation of a patient with implantable cardiac rhythm devices. The implantable device technology uses complementary metal-oxide semiconductor (CMOS) which are vulnerable to damage by the therapeutic doses of radiation, but it can vary according to the type of device in use.
North America is expected to have the largest market share for cardiac rhythm management, due to developed healthcare infrastructure, government initiatives, rising number of death due to cardiovascular diseases, and rising incidence of arrhythmias demanding more cardiac implants. According to a report by the US CDC, more than 75,000 hospitalizations are attributed atrial fibrillation. Also, it highlighted that a large part of the American population suffers from atrial fibrillation.
Companies Mentioned
- Abbott
- Abiomed
- Biotronik Se & Co Kg
- Boston Scientific Corporation
- Koninklijke Philips Nv
- Livanova Plc
- Medtronic Plc
- Schiller Ag
- Shenzhen Mindray Biomedical Electronics Co. LTD
- Zoll Medical Corporation
Key Topics Covered:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Major Players
10. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/bl97tb/global_cardiac?w=4
